- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Promoter group entities Sunev and Spine approved a merger. Sunev's 17.21% equity stake in Venus Remedies will vest in Spine. This is an internal promoter restructuring; aggregate promoter shareholding and company control remain unchanged.